Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,407 signal articles · 190 in last 24h · 121,335 total before filter · latest 1h ago
190last 24h
1273last 7d
219● bullish (7d)
146● bearish (7d)
205publishers
AllMacro222Earnings434M&A100Regulatory22Product9Analyst15
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds
Insider Monkey66d agobullish
Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Stealing the Spotlight from Wall Street Giants. Hims & Hers rallied by 12.49 percent on Monday to finish at $30.17 apiece, as investors cheered rosy growth prospects for the obesity market, alongside its efforts to bridge the gap between the rapidly increasing demand […]

D-Wave (QBTS) Soars 12% on US-Iran Deal Cheer
Insider Monkey66d agobullish
D-Wave (QBTS) Soars 12% on US-Iran Deal Cheer

D-Wave Quantum Inc. (NYSE:QBTS) is one of the 10 Stocks Stealing the Spotlight from Wall Street Giants. D-Wave Quantum saw its share prices climb by 12.37 percent on Monday to close at $26.26 apiece, mirroring a wider market optimism, while investors increased their exposure in industries with rosy long-term prospects. The stock climbed alongside its […]

How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum
Simply Wall St.66d agobullish
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum

West Pharmaceutical Services recently reported strong first-quarter 2026 results, highlighting robust growth in biologics-related high-value components and self-injection delivery devices, and raised its full-year 2026 revenue and adjusted EPS guidance. The company emphasized its role as a critical part of injectable-drug infrastructure rather than a conventional packaging supplier, underlining how its specialized high-value products support complex biologic therapies. Next, we’ll examine...

Why Are Booking (BKNG) Shares Soaring Today
StockStory66d agobullish
Why Are Booking (BKNG) Shares Soaring Today

Shares of online travel agency Booking Holdings (NASDAQ:BKNG) jumped 6.3% in the morning session after the Trump administration announced a new peace deal that would lead to the reopening of the Strait of Hormuz.

Why AI investor Aschenbrenner is shorting Nvidia, buying HIVE
TheStreet66d agobullish
Why AI investor Aschenbrenner is shorting Nvidia, buying HIVE

Leopold Aschenbrenner, the former OpenAI researcher whose AI-focused fund posted blockbuster 2025 returns, used his Q1 2026 13F to do something counterintuitive: stack roughly $8.5 billion of put options against Nvidia while piling into Bitcoin miners pivoting to AI, including a new position in ...

Wall Street rallies, Dow ends with record on US-Iran deal
Reuters Videos66d agobullishVIDEO
Wall Street rallies, Dow ends with record on US-Iran deal

<body><p>STORY: Wall Street's main indexes rallied on Monday, with the Dow gaining nearly 1% to notch a record-high close, the S&P 500 climbing about one-and-two-thirds percent and the Nasdaq soaring 3%.</p><p>Investors cheered the news of a preliminary deal between the U.S. and Iran to end their war and reopen the Strait of Hormuz.&nbsp;</p><p>Kevin Mahn is president and chief investment officer at Hennion & Walsh Asset Management.</p><p>"I believe that the theme of the day for investors is that a deal has been reached. We think the strait has been opened, we think, and the market has rallied, at least for now. Obviously, if the first two tenets of that theme start to get unwound, then we're going to see this market rally go in the opposite direction. But as it stands now, we believe that ultimately a deal between the U.S. and Iran will be signed in Switzerland on Friday and in all likelihood, tankers will start to pass through the Strait of Hormuz, and that should start to ease inflationary pressures that are a result of higher oil prices that have been in place now since the beginning of March."</p><p>U.S. crude futures settled down 4.9% and hit their lowest level since March, helping to lift shares of energy-sensitive airline and cruise companies and hurting energy stocks.</p><p>Easing inflation fears also helped boost technology stocks as investors were more comfortable taking on riskier bets.</p><p>Chip giant Nvidia gained 3.5% and Micron Technology jumped nearly 11% after at least two brokerages sharply raised their price targets for the stock.</p><p>Investors now turn their attention to the Federal Reserve's two-day policy meeting, which concludes Wednesday.</p><p>Traders expect the central bank to leave interest rates unchanged, but they'll be watching closely for signals from Kevin Warsh in his first press conference as Fed chair.</p></body>

Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report
Exec Edge66d agobullish
Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report

Download the Complete Report Here Aurora Cannabis Inc. (ACB) Y26 Beat Underscores Medical Cannabis Momentum; FY27 Reset Reflects Canadian Reimbursement Cut, but Long-Term Growth Remains on Track. Key Takeaways: FY26 topped management’s outlook, with net revenue up 11% to C$320.6 million and medical cannabis revenue up 18%. 4Q revenue grew 10% y/y to C$84.8 million, […] The post Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report appeared first on

Johnson & Johnson (JNJ) Stock After 55% One-Year Surge Is There Still Value Here
Simply Wall St.66d agobullish
Johnson & Johnson (JNJ) Stock After 55% One-Year Surge Is There Still Value Here

Wondering if Johnson & Johnson at around US$235.66 is still a solid deal or starting to look fully priced? This article walks through the numbers so you can judge the stock's value with more confidence. The stock closed at US$235.66 and has returns of 1.5% over 7 days, 3.9% over 30 days, 13.7% year to date, 55.6% over 1 year, 56.6% over 3 years, and 65.6% over 5 years. This gives useful context before looking at valuation. Recent headlines around Johnson & Johnson have focused on its...

Forget Micron: 1 Record-Breaking Cloud Powerhouse to Buy Hand Over Fist After the Pullback
24/7 Wall St.66d agobullish
Forget Micron: 1 Record-Breaking Cloud Powerhouse to Buy Hand Over Fist After the Pullback

Micron Technology (NASDAQ:MU) is the chip stock dominating every feed after its memory business rode the AI cycle to a $1.12 trillion market cap and a 760.37% one-year run. But here’s what you should actually be watching. The Crowded Trade at the Top of the Cycle Memory margins do not stay at 74% forever. Micron ... Forget Micron: 1 Record-Breaking Cloud Powerhouse to Buy Hand Over Fist After the Pullback

3 Reasons FBNC is Risky and 1 Stock to Buy Instead
StockStory66d agobullish
3 Reasons FBNC is Risky and 1 Stock to Buy Instead

Over the past six months, First Bancorp has been a great trade, beating the S&P 500 by 7.2%. Its stock price has climbed to $61.79, representing a healthy 15.6% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.